The stock opened with a loss of 3.12% this Friday, setting the price at €43.50. This movement deepens a downward trend observed this week, with a cumulative decline of 5.84% over the past seven days. Trading is occurring at a very measured pace, with volumes representing barely 0.03% of the company's capital, indicating extremely reduced commercial activity. However, from a longer-term perspective, the stock maintains a positive trajectory: it has gained 14.02% over three months and 126.5% since the beginning of the last year.
Market Context
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
The market context is weighing on all stock exchanges. The CAC 40 is down 0.34% this morning, reflecting a widespread risk aversion particularly affecting the technology and defense sectors. Graphically, EXOSENS is set at €43.50, below its 50-day moving average of €45.58, indicating short-term bearish pressure. Nevertheless, the price remains comfortably above its 200-day moving average of €39.03, confirming a well-established bullish structure over the past year.
Technical Analysis
Technically, the stock is hovering around the support threshold identified at €43.45, surpassing it by only €0.05. The Relative Strength Index, positioned at 33, is approaching the conventionally established oversold zone below 30, while the MACD shows a negative setup with its main line at -0.28 remaining below the signal line set at 0.11. This short-term technical structure contrasts with the stock's maintenance well above long-term support levels, highlighting the duality of the current graphical context.
Nous sommes fiers de présenter notre performance sur les neuf premiers mois de l’année 2025, qui témoignent d'une croissance soutenue du chiffre d'affaires et de la marge brute ajustée, portée par la forte dynamique du secteur de la Défense.
Marché de la Défense très dynamique, forte demande pour la vision nocturne et les systèmes pour drones/anti-drones, croissance soutenue en Europe avec contribution des États-Unis et de l’Asie-Pacifique. Lancement commercial réussi des tubes 5G (plus de 5 000 commandes avant lancement).
Risks mentioned
Cession de l’activité Amplification par Micro-ondes entraînant une perte comptable sans impact de trésorerie en 2025
Dépendance aux budgets de Défense et aux évolutions géopolitiques
Risque d'intégration des acquisitions récentes
Incertitudes de la demande dans les Sciences de la Vie (marché américain)
Opportunities identified
Croissance adressable liée à la vision nocturne et aux applications drones/anti-drones
Commercialisation des tubes 5G avec commandes significatives (>5 000 tubes)
Expansion des capacités de production (+40% d’ici 2027) soutenant le développement commercial
Effets de croissance externe (Noxant, NVLS, Phasics) élargissant le marché adressable
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
